Cargando…

Salpingectomy and the Risk of Ovarian Cancer in Ontario

IMPORTANCE: A body of pathological and clinical evidence supports the position that the fallopian tube is the site of origin for a large proportion of high-grade serous ovarian cancers. Consequently, salpingectomy is now considered for permanent contraception (in lieu of tubal ligation) or ovarian c...

Descripción completa

Detalles Bibliográficos
Autores principales: Giannakeas, Vasily, Murji, Ally, Lipscombe, Lorraine L., Narod, Steven A., Kotsopoulos, Joanne
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10422181/
https://www.ncbi.nlm.nih.gov/pubmed/37566421
http://dx.doi.org/10.1001/jamanetworkopen.2023.27198
_version_ 1785089140912553984
author Giannakeas, Vasily
Murji, Ally
Lipscombe, Lorraine L.
Narod, Steven A.
Kotsopoulos, Joanne
author_facet Giannakeas, Vasily
Murji, Ally
Lipscombe, Lorraine L.
Narod, Steven A.
Kotsopoulos, Joanne
author_sort Giannakeas, Vasily
collection PubMed
description IMPORTANCE: A body of pathological and clinical evidence supports the position that the fallopian tube is the site of origin for a large proportion of high-grade serous ovarian cancers. Consequently, salpingectomy is now considered for permanent contraception (in lieu of tubal ligation) or ovarian cancer prevention (performed opportunistically at the time of surgical procedures for benign gynecologic conditions). OBJECTIVE: To evaluate the association between salpingectomy and the risk of invasive epithelial ovarian, fallopian tube, and peritoneal cancer. DESIGN, SETTING, AND PARTICIPANTS: This population-based retrospective cohort study included all women aged 18 to 80 years who were eligible for health care services in Ontario, Canada. Participants were identified using administrative health databases from Ontario between January 1, 1992, and December 31, 2019. A total of 131 516 women were included in the primary (matched) analysis. Women were followed up until December 31, 2021. EXPOSURES: Salpingectomy (with and without hysterectomy) vs no pelvic procedure (control condition) among women in the general population. MAIN OUTCOMES AND MEASURES: Women with a unilateral or bilateral salpingectomy in Ontario between April 1, 1992, and December 31, 2019, were matched 1:3 to women with no pelvic procedure from the general population. Cox proportional hazards regression models were used to estimate the hazard ratios (HRs) and 95% CIs for ovarian, fallopian tube, and peritoneal cancer combined. RESULTS: Among 131 516 women (mean [SD] age, 42.2 [7.6] years), 32 879 underwent a unilateral or bilateral salpingectomy, and 98 637 did not undergo a pelvic procedure. After a mean (range) follow-up of 7.4 (0-29.2) years in the salpingectomy group and 7.5 (0-29.2) years in the nonsurgical control group, there were 31 incident cancers (0.09%) and 117 incident cancers (0.12%), respectively (HR, 0.82; 95% CI, 0.55-1.21). The HR for cancer incidence was 0.87 (95% CI, 0.53-1.44) when comparing those with salpingectomy vs those with hysterectomy alone. CONCLUSIONS AND RELEVANCE: In this cohort study, no association was found between salpingectomy and the risk of ovarian cancer; however, this observation was based on few incident cases and a relatively short follow-up time. Studies with additional years of follow-up are necessary to define the true level of potential risk reduction with salpingectomy, although longer follow-up will also be a challenge unless collaborative efforts that pool data are undertaken.
format Online
Article
Text
id pubmed-10422181
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher American Medical Association
record_format MEDLINE/PubMed
spelling pubmed-104221812023-08-13 Salpingectomy and the Risk of Ovarian Cancer in Ontario Giannakeas, Vasily Murji, Ally Lipscombe, Lorraine L. Narod, Steven A. Kotsopoulos, Joanne JAMA Netw Open Original Investigation IMPORTANCE: A body of pathological and clinical evidence supports the position that the fallopian tube is the site of origin for a large proportion of high-grade serous ovarian cancers. Consequently, salpingectomy is now considered for permanent contraception (in lieu of tubal ligation) or ovarian cancer prevention (performed opportunistically at the time of surgical procedures for benign gynecologic conditions). OBJECTIVE: To evaluate the association between salpingectomy and the risk of invasive epithelial ovarian, fallopian tube, and peritoneal cancer. DESIGN, SETTING, AND PARTICIPANTS: This population-based retrospective cohort study included all women aged 18 to 80 years who were eligible for health care services in Ontario, Canada. Participants were identified using administrative health databases from Ontario between January 1, 1992, and December 31, 2019. A total of 131 516 women were included in the primary (matched) analysis. Women were followed up until December 31, 2021. EXPOSURES: Salpingectomy (with and without hysterectomy) vs no pelvic procedure (control condition) among women in the general population. MAIN OUTCOMES AND MEASURES: Women with a unilateral or bilateral salpingectomy in Ontario between April 1, 1992, and December 31, 2019, were matched 1:3 to women with no pelvic procedure from the general population. Cox proportional hazards regression models were used to estimate the hazard ratios (HRs) and 95% CIs for ovarian, fallopian tube, and peritoneal cancer combined. RESULTS: Among 131 516 women (mean [SD] age, 42.2 [7.6] years), 32 879 underwent a unilateral or bilateral salpingectomy, and 98 637 did not undergo a pelvic procedure. After a mean (range) follow-up of 7.4 (0-29.2) years in the salpingectomy group and 7.5 (0-29.2) years in the nonsurgical control group, there were 31 incident cancers (0.09%) and 117 incident cancers (0.12%), respectively (HR, 0.82; 95% CI, 0.55-1.21). The HR for cancer incidence was 0.87 (95% CI, 0.53-1.44) when comparing those with salpingectomy vs those with hysterectomy alone. CONCLUSIONS AND RELEVANCE: In this cohort study, no association was found between salpingectomy and the risk of ovarian cancer; however, this observation was based on few incident cases and a relatively short follow-up time. Studies with additional years of follow-up are necessary to define the true level of potential risk reduction with salpingectomy, although longer follow-up will also be a challenge unless collaborative efforts that pool data are undertaken. American Medical Association 2023-08-11 /pmc/articles/PMC10422181/ /pubmed/37566421 http://dx.doi.org/10.1001/jamanetworkopen.2023.27198 Text en Copyright 2023 Giannakeas V et al. JAMA Network Open. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the CC-BY License.
spellingShingle Original Investigation
Giannakeas, Vasily
Murji, Ally
Lipscombe, Lorraine L.
Narod, Steven A.
Kotsopoulos, Joanne
Salpingectomy and the Risk of Ovarian Cancer in Ontario
title Salpingectomy and the Risk of Ovarian Cancer in Ontario
title_full Salpingectomy and the Risk of Ovarian Cancer in Ontario
title_fullStr Salpingectomy and the Risk of Ovarian Cancer in Ontario
title_full_unstemmed Salpingectomy and the Risk of Ovarian Cancer in Ontario
title_short Salpingectomy and the Risk of Ovarian Cancer in Ontario
title_sort salpingectomy and the risk of ovarian cancer in ontario
topic Original Investigation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10422181/
https://www.ncbi.nlm.nih.gov/pubmed/37566421
http://dx.doi.org/10.1001/jamanetworkopen.2023.27198
work_keys_str_mv AT giannakeasvasily salpingectomyandtheriskofovariancancerinontario
AT murjially salpingectomyandtheriskofovariancancerinontario
AT lipscombelorrainel salpingectomyandtheriskofovariancancerinontario
AT narodstevena salpingectomyandtheriskofovariancancerinontario
AT kotsopoulosjoanne salpingectomyandtheriskofovariancancerinontario